Synthesis of Ni(II) complexes shows high oxygen evolution activity, suggesting commercial viability for renewable energy applications.
Herein, we reports the synthesis of 2-benzoylpyridine-derived ligands with two different substituents, namely, N-(4-chlorophenyl)-2-(phenyl(pyridin-2-yl)methylene)hydrazine-1-carbothioamide (HClPhBHCT) and N-(4-methylphenyl)-2-(phenyl(pyridin-2-yl)methylene)hydrazine-1-carbothioamide (HMPhBHCT) and their corresponding Ni(II) complexes [Ni(ClPhB)Cl] and [Ni(MePhB)Cl], respectively. They are characterized using spectroscopic methods, single-crystal X-ray diffraction, and cyclic voltammetry. Subsequently, these nickel complexes were employed for the oxygen evolution reaction (OER) under alkaline conditions. Among the two complexes, [Ni(MePhB)Cl] delivers a current density of 10 mA cm-2 at the lowest overpotential of 330 mV with a Tafel slope of 71 mV dec-1. The complex undergoes electrochemical anodic activation to form a [Ni(MePhB)Cl]/Ni(O)OH interface acting as an active catalyst, as established by the spectroscopic and electrochemical characterizations. The vast electrochemically active surface area and, consequently, large number of active sites of [Ni(MePhB)Cl] may be responsible for its remarkable performance. In addition to its strong OER activity, [Ni(MePhB)Cl] showed outstanding long-term stability on continuous operation, supporting its potential use in commercial systems.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: